VAMP1 Gene Spastic Ataxia Type 1 Autosomal Dominant Genetic Test
At DNA Labs UAE, we offer the VAMP1 Gene Spastic Ataxia Type 1 Autosomal Dominant Genetic Test for individuals who may be at risk for this genetic condition. This test is designed to identify mutations in the VAMP1 gene, which is associated with spastic ataxia type 1.
Test Components
The VAMP1 Gene Spastic Ataxia Type 1 Autosomal Dominant Genetic Test includes the following components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Before undergoing the VAMP1 Gene Spastic Ataxia Type 1 Autosomal Dominant Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by this condition.
Test Details
The VAMP1 gene, also known as Vesicle-associated membrane protein 1, is associated with spastic ataxia type 1. This condition is inherited in an autosomal dominant manner, meaning that a mutation in one copy of the VAMP1 gene is sufficient to cause the disease.
Spastic ataxia type 1 is a neurodegenerative disorder characterized by a combination of spasticity (stiffness and increased muscle tone) and ataxia (lack of coordination and balance). Symptoms typically appear in adulthood and progressively worsen over time.
NGS (Next-Generation Sequencing) genetic testing is used to analyze multiple genes simultaneously for the presence of mutations or variations. In the case of spastic ataxia type 1, NGS genetic testing can identify mutations in the VAMP1 gene associated with the condition.
The genetic test involves obtaining a DNA sample, usually through a blood sample or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any mutations or variations in the VAMP1 gene.
The results of the genetic test can help confirm a diagnosis of spastic ataxia type 1 and provide information about the specific mutation present in the VAMP1 gene.
It is important to note that genetic testing for spastic ataxia type 1 is typically recommended for individuals who have symptoms consistent with the condition or have a family history of the disease. Genetic counseling is also recommended before and after testing to discuss the implications of the results and provide support for individuals and their families.
| Test Name | VAMP1 Gene Spastic ataxia type 1 autosomal dominant Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for VAMP1 Gene Spastic ataxia type 1, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with VAMP1 Gene Spastic ataxia type 1, autosomal dominant |
| Test Details |
VAMP1 gene, also known as Vesicle-associated membrane protein 1, is a gene associated with a condition called spastic ataxia type 1. This condition is inherited in an autosomal dominant manner, meaning that a mutation in one copy of the VAMP1 gene is sufficient to cause the disease. Spastic ataxia type 1 is a neurodegenerative disorder characterized by a combination of spasticity (stiffness and increased muscle tone) and ataxia (lack of coordination and balance). Symptoms typically appear in adulthood and progressively worsen over time. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously for the presence of mutations or variations. In the case of spastic ataxia type 1, NGS genetic testing can be used to identify mutations in the VAMP1 gene that are associated with the condition. The genetic test involves obtaining a DNA sample, typically through a blood sample or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any mutations or variations in the VAMP1 gene. The results of the genetic test can help confirm a diagnosis of spastic ataxia type 1 and provide information about the specific mutation present in the VAMP1 gene. It is important to note that genetic testing for spastic ataxia type 1 is typically recommended for individuals who have symptoms consistent with the condition or have a family history of the disease. Genetic counseling is also recommended before and after testing to discuss the implications of the results and provide support for individuals and their families. |
